Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Acceptance of recommendations by a pharmacogenetics clinic.

Pharmacogenomics - 1 Jan 2026

Al Alshaykh Hana, Cicali Emily, Cavallari Larisa H, Huber J Katherine, Williams Roy, Alayban Ghadah, Asiri Waad, Mohamed Gamal, Akhavan Neeka, Holland Neal, Maska Edlira, Nagoshi Ying, Panna Danielle, Wright Ashleigh, Portillo Romero Jessica, Wiisanen Kristin

Abstract excerpt

AIM: Assess the acceptance of genotype-based pharmacist recommendations made within a pharmacogenetics (PGx) clinic. METHODS: Patients seen by the UF Health PGx clinic between 2017 and 2022 were included in a retrospective chart review. We evaluated CYP2D6/CYP2C19 and three drug classes (opioids, selective serotonin reuptake inhibitors [SSRIs], proton pump inhibitors [PPIs]). Gene-drug pairings were classified as...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Cytochrome P-450 CYP2C19

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cytochrome P-450 CYP2D6

Share to CYP2C19 gene

Share to Genotype

Share to Pharmacogenetics

Share to Proton Pump Inhibitors

Share to Selective Serotonin Reuptake Inhibitors

Source

Open in PubMed Open full text

Identifiers

PMID: 41873481
DOI: 10.1080/14622416.2026.2640827
PMCID: PMC13078218

Genes

CYP2C19

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Acceptance of recommendations by a pharmacogenetics clinic.PMID 41873481Read ↗

Implementation of Pharmacogenetics in First-Line Care: Evaluation of Its Use by General PractitionersSemantic proximity Read ↗

Genotype, phenotype, and medication recommendation agreement among commercial pharmacogenetic-based decision support tools.Semantic proximity Read ↗

Design and Early Implementation Successes and Challenges of a Pharmacogenetics Consult ClinicSemantic proximity Read ↗

Self-reported pharmacogenetic medication use in the <i>Our Future Health</i> cohortSemantic proximity Read ↗

Prevalence and types of inconsistencies in clinical pharmacogenetic recommendations among major U.S. sourcesSemantic proximity Read ↗

A Framework to Quantify Disparities in Pharmacogenomic Treatment Concordance and Drug Response Outcomes.Semantic proximity Read ↗

A Framework to Quantify Disparities in Pharmacogenomic Treatment Concordance and Drug Response OutcomesSemantic proximity Read ↗

Genotype-predicted drug response phenotypes and their co-occurrence with dispensed medicines among 738,531 participants in the UK Our Future Health studySemantic proximity Read ↗

Variability Between Clinical Pharmacogenetics Implementation Consortium (CPIC®) Guidelines and a Commercial Pharmacogenetics Laboratory in Genotype to Phenotype Interpretations For Patients Utilizing PsychotropicsSemantic proximity Read ↗

Pharmacogenetics testing for poor response to antidepressants: a transnosographic case seriesSemantic proximity Read ↗

Adherence to International Pharmacogenomic Recommendations in Paediatric Cancer Care: A Cohort Analysis Embedded Within the MARVEL-PIC Randomised TrialSemantic proximity Read ↗

[A DNA medication pass for everyone?]Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.